共 50 条
- [6] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Current Hematologic Malignancy Reports, 2023, 18 : 130 - 143
- [10] Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (04): : 319 - 332